Hyejin Mo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hyejin Mo has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- In Mok Jung
Department of Surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea
8 shared publications - Seung-Kee Min
Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
6 shared publications - Ahram Han
Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
5 shared publications - Sangil Min
Division of Transplantation and Vascular Surgery, Department of Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea
5 shared publications - Jongwon Ha
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
4 shared publications - Sanghyun Ahn
Division of Vascular Surgery, Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
4 shared publications
Latest Publications
- 11 August 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (2) , e54
Midterm outcomes of off-the-shelf multibranched versus physician-modified endografts for endovascular repair of complex and thoracoabdominal aortic aneurysms: A systematic review and meta-analysis
- 11 August 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (2) , e54
Midterm outcomes of off-the-shelf multibranched versus physician-modified endografts for endovascular repair of complex and thoracoabdominal aortic aneurysms: A systematic review and meta-analysis
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (5) , 298-303
Superficial venous procedures improve clinical and hemodynamic outcomes in patients with concomitant deep venous reflux: a prospective observational study
Mo H, et al. Ann Surg Treat Res. 2026 Nov;111(5):298-303. https://doi.org/10.4174/astr.2026.111.5.298
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (5) , 298-303
Open AccessSuperficial venous procedures improve clinical and hemodynamic outcomes in patients with concomitant deep venous reflux: a prospective observational study
Mo H, et al. Ann Surg Treat Res. 2026 Nov;111(5):298-303. https://doi.org/10.4174/astr.2026.111.5.298
- Open Access
- 1 November 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 44 (6) , 984-995
Predictive models for posttransplant diabetes mellitus in kidney transplant recipients using machine learning and deep learning approach: a nationwide cohort study from South Korea
Background: Posttransplant diabetes mellitus (PTDM) complicates kidney transplant recipients (KTRs) in morbidity and mortality. This study aimed to predict PTDM risk in KTRs using machine learning and deep learning models. Methods: Data were obtained from the Korea Organ Transplantation Registry, a nationwide cohort study of KTRs. Four machine learning algorithms, including eXtreme Gradient Boosting (XGBoost), CatBoost, light gradient boosting machine and logistic regression, and deep learning were implemented on 41 pretransplant and 31 posttransplant variables to predict PTDM. Model performance was assessed using the area under the curve (AUC) of the receiver operating characteristic curve, accuracy, precision, recall, and F1 score. Results: Among 3,213 KTRs, 497 patients (15.5%) developed PTDM within 1 year. The PTDM group had higher age, body mass index (BMI), triglyceride level, and prevalence of hypertension and cardiovascular disease, and lower total cholesterol level at baseline than the No-PTDM group. The XGBoost model showed the highest AUC (0.738) and F1 score (0.42), and modest accuracy (0.86), while the CatBoost model exhibited the highest accuracy (0.87) and precision (0.79). Feature importance in XGBoost was highest for recipient age, followed by baseline BMI, triglyceride level at posttransplant 6 months, baseline glycated hemoglobin and high-density lipoprotein cholesterol level, white blood cell (WBC) count and serum uric acid level at 6 months, baseline WBC count, and tacrolimus trough level at discharge.Conclusion: The XGBoost model demonstrated the best performance for predicting PTDM within 1 year, offering an accurate tool for early identification and personalized care of high-risk KTRs for PTDM.
- 1 November 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 44 (6) , 984-995
Open AccessPredictive models for posttransplant diabetes mellitus in kidney transplant recipients using machine learning and deep learning approach: a nationwide cohort study from South Korea
Background: Posttransplant diabetes mellitus (PTDM) complicates kidney transplant recipients (KTRs) in morbidity and mortality. This study aimed to predict PTDM risk in KTRs using machine learning and deep learning models. Methods: Data were obtained from the Korea Organ Transplantation Registry, a nationwide cohort study of KTRs. Four machine learning algorithms, including eXtreme Gradient Boosting (XGBoost), CatBoost, light gradient boosting machine and logistic regression, and deep learning were implemented on 41 pretransplant and 31 posttransplant variables to predict PTDM. Model performance was assessed using the area under the curve (AUC) of the receiver operating characteristic curve, accuracy, precision, recall, and F1 score. Results: Among 3,213 KTRs, 497 patients (15.5%) developed PTDM within 1 year. The PTDM group had higher age, body mass index (BMI), triglyceride level, and prevalence of hypertension and cardiovascular disease, and lower total cholesterol level at baseline than the No-PTDM group. The XGBoost model showed the highest AUC (0.738) and F1 score (0.42), and modest accuracy (0.86), while the CatBoost model exhibited the highest accuracy (0.87) and precision (0.79). Feature importance in XGBoost was highest for recipient age, followed by baseline BMI, triglyceride level at posttransplant 6 months, baseline glycated hemoglobin and high-density lipoprotein cholesterol level, white blood cell (WBC) count and serum uric acid level at 6 months, baseline WBC count, and tacrolimus trough level at discharge.Conclusion: The XGBoost model demonstrated the best performance for predicting PTDM within 1 year, offering an accurate tool for early identification and personalized care of high-risk KTRs for PTDM.
- Open Access
- 1 July 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 44 (4) , 679-692
Framingham risk score is a useful indicator of posttransplant cardiovascular events and survival among Korean kidney transplant recipients: a nationwide, prospective cohort study
Background: Cardiovascular disease is an important risk factor for mortality among kidney transplant recipients. In this study, we aimed to investigate the association between cardiovascular risk score at kidney transplantation and long-term outcomes of patients. Methods: In this prospective, observational cohort study, we enrolled kidney transplant recipients who participated in the Korean Organ Transplantation Registry and underwent transplantation between April 2014 and December 2019. The cardiovascular risk status of kidney transplant recipients was assessed using the Framingham risk score. All-cause mortality, major adverse cardiovascular events, allograft failure, estimated glomerular filtration rates (eGFRs), and composite outcomes were evaluated after kidney transplantation. Results: Of the 4,682 kidney transplant recipients, 96 died during 30.7 ± 19.1 months of follow-up. The Kaplan-Meier survival analysis results showed that high Framingham risk scores were associated with all-cause mortality, major adverse cardiovascular events, and composite outcomes. According to the multivariable Cox analysis, high Framingham risk scores were associated with an increased risk of mortality (hazard ratio [HR], 3.20; 95% confidence interval [CI], 1.30–7.91), major adverse cardiovascular events (HR, 8.43; 95% CI, 2.41–29.52), and composite outcomes (HR, 2.05; 95% CI, 1.19–3.46). The eGFRs after transplantation were significantly higher among patients in the low Framingham risk score group (p < 0.001). However, Framingham risk scores were not associated with graft loss or rapid decline in eGFRs. Conclusion: The Framingham risk score is a useful indicator of cardiovascular events, mortality, and kidney function after kidney transplantation.
- 1 July 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 44 (4) , 679-692
Open AccessFramingham risk score is a useful indicator of posttransplant cardiovascular events and survival among Korean kidney transplant recipients: a nationwide, prospective cohort study
Background: Cardiovascular disease is an important risk factor for mortality among kidney transplant recipients. In this study, we aimed to investigate the association between cardiovascular risk score at kidney transplantation and long-term outcomes of patients. Methods: In this prospective, observational cohort study, we enrolled kidney transplant recipients who participated in the Korean Organ Transplantation Registry and underwent transplantation between April 2014 and December 2019. The cardiovascular risk status of kidney transplant recipients was assessed using the Framingham risk score. All-cause mortality, major adverse cardiovascular events, allograft failure, estimated glomerular filtration rates (eGFRs), and composite outcomes were evaluated after kidney transplantation. Results: Of the 4,682 kidney transplant recipients, 96 died during 30.7 ± 19.1 months of follow-up. The Kaplan-Meier survival analysis results showed that high Framingham risk scores were associated with all-cause mortality, major adverse cardiovascular events, and composite outcomes. According to the multivariable Cox analysis, high Framingham risk scores were associated with an increased risk of mortality (hazard ratio [HR], 3.20; 95% confidence interval [CI], 1.30–7.91), major adverse cardiovascular events (HR, 8.43; 95% CI, 2.41–29.52), and composite outcomes (HR, 2.05; 95% CI, 1.19–3.46). The eGFRs after transplantation were significantly higher among patients in the low Framingham risk score group (p < 0.001). However, Framingham risk scores were not associated with graft loss or rapid decline in eGFRs. Conclusion: The Framingham risk score is a useful indicator of cardiovascular events, mortality, and kidney function after kidney transplantation.
- 9 May 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 120, 103-107
Long-Term Results of Radiofrequency Ablation for Unilateral Great Saphenous Vein Insufficiency and Hemodynamic Changes in the Contralateral Leg
- 9 May 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 120, 103-107
Long-Term Results of Radiofrequency Ablation for Unilateral Great Saphenous Vein Insufficiency and Hemodynamic Changes in the Contralateral Leg
- 10 April 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (2) , 238-244
Long Term Outcomes of Non-operative Treatment for Popliteal Artery Entrapment Syndrome: A Multicentre Study
- 10 April 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (2) , 238-244
Long Term Outcomes of Non-operative Treatment for Popliteal Artery Entrapment Syndrome: A Multicentre Study
- Open Access
- 9 January 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Safety of direct oral anticoagulants in hemodialysis patients with venous thromboembolism: an analysis using the Korean National Health Insurance Service database
Limited data exist regarding the safety of direct oral anticoagulants in hemodialysis patients with venous thromboembolic disease. This study aims to investigate the safety of direct oral anticoagulants in hemodialysis patients using national data. The National Health Insurance Service database was retrospectively queried to identify chronic kidney disease patients who took direct oral anticoagulants for venous thromboembolism from 2008 to 2019. Bleeding complications and all-cause mortality were compared between 118 hemodialysis patients (HD group) and 227 matched chronic kidney disease patients not undergoing hemodialysis (CKD group). The use of direct oral anticoagulants among chronic kidney disease patients, with or without dialysis, increased over time. The incidence rate of all-cause mortality per 100 person-years was 38.1 in the HD group and 10.5 in the CKD group (adjusted hazard ratio [HR], 3.28; 95% confidence interval [CI], 2.27-4.75; p < 0.001). When considering death as a competing risk, there was no significant difference in gastrointestinal bleeding (adjusted HR, 1.61; 95% CI, 0.91-2.88; p = 0.115) and intracranial bleeding (adjusted HR, 1.86; 95% CI, 0.73-4.74; p = 0.193) between the HD and CKD groups. In comparison to chronic kidney disease patients not on hemodialysis, the major bleeding risk, including gastrointestinal and intracranial bleeding, was comparable in hemodialysis patients using direct oral anticoagulants for venous thromboembolism.
- 9 January 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Open AccessSafety of direct oral anticoagulants in hemodialysis patients with venous thromboembolism: an analysis using the Korean National Health Insurance Service database
Limited data exist regarding the safety of direct oral anticoagulants in hemodialysis patients with venous thromboembolic disease. This study aims to investigate the safety of direct oral anticoagulants in hemodialysis patients using national data. The National Health Insurance Service database was retrospectively queried to identify chronic kidney disease patients who took direct oral anticoagulants for venous thromboembolism from 2008 to 2019. Bleeding complications and all-cause mortality were compared between 118 hemodialysis patients (HD group) and 227 matched chronic kidney disease patients not undergoing hemodialysis (CKD group). The use of direct oral anticoagulants among chronic kidney disease patients, with or without dialysis, increased over time. The incidence rate of all-cause mortality per 100 person-years was 38.1 in the HD group and 10.5 in the CKD group (adjusted hazard ratio [HR], 3.28; 95% confidence interval [CI], 2.27-4.75; p < 0.001). When considering death as a competing risk, there was no significant difference in gastrointestinal bleeding (adjusted HR, 1.61; 95% CI, 0.91-2.88; p = 0.115) and intracranial bleeding (adjusted HR, 1.86; 95% CI, 0.73-4.74; p = 0.193) between the HD and CKD groups. In comparison to chronic kidney disease patients not on hemodialysis, the major bleeding risk, including gastrointestinal and intracranial bleeding, was comparable in hemodialysis patients using direct oral anticoagulants for venous thromboembolism.
- 1 February 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 102, 152-159
A 20-Year Analysis of Ruptured Abdominal Aortic Aneurysm Outcomes and Associated Factors in Korea
- 1 February 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 102, 152-159
A 20-Year Analysis of Ruptured Abdominal Aortic Aneurysm Outcomes and Associated Factors in Korea
- Open Access
- 22 November 2023
- Published by The Korean Society for Vascular Surgery in Vascular Specialist International
- Vol. 39 (4) , 38
Infection of the Aortic Stent Graft to Treat Arterioureteral Fistula
Soomin Lee, Hyejin Mo, and In Mok Jung. Vasc Specialist Int 2023;39:. https://doi.org/10.5758/vsi.230072
- 22 November 2023
- Published by The Korean Society for Vascular Surgery in Vascular Specialist International
- Vol. 39 (4) , 38
Open AccessInfection of the Aortic Stent Graft to Treat Arterioureteral Fistula
Soomin Lee, Hyejin Mo, and In Mok Jung. Vasc Specialist Int 2023;39:. https://doi.org/10.5758/vsi.230072